<Suppliers Price>

Fmoc-Val-OH

Names

[ CAS No. ]:
68858-20-8

[ Name ]:
Fmoc-Val-OH

[Synonym ]:
L-Valine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-valine
N-Fmoc-Val-OH (N-Fmoc-L-valine)
FMco-Val-OH
N-FMOC-L-VAL
FMOC-L-VAL-OH
FMOC-VAL
FMOC-VAL-OH
MFCD00037124
N-((9H-Fluoren-9-ylmethoxy)carbonyl)-L-valine
FMOC-VALINE
FMOC-L-VALINE
N-Fmoc-L-valine
FMOC-L-VAL
N-FMOC-VAL-OH
Fmoc-Valine-OH
EINECS 272-515-0

Biological Activity

[Description]:

Fmoc-L-Val-OH is a valine derivative[1].

[Related Catalog]:

Research Areas >> Others
Signaling Pathways >> Others >> Others

[In Vitro]

Amino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances[1].

[References]

[1]. Luckose F, et al. Effects of amino acid derivatives on physical, mental, and physiological activities. Crit Rev Food Sci Nutr. 2015;55(13):1793-1144.

Chemical & Physical Properties

[ Density]:
1.2±0.1 g/cm3

[ Boiling Point ]:
551.8±33.0 °C at 760 mmHg

[ Melting Point ]:
143-147ºC

[ Molecular Formula ]:
C20H21NO4

[ Molecular Weight ]:
339.385

[ Flash Point ]:
287.5±25.4 °C

[ Exact Mass ]:
339.147064

[ PSA ]:
79.12000

[ LogP ]:
4.42

[ Vapour Pressure ]:
0.0±1.6 mmHg at 25°C

[ Index of Refraction ]:
1.590

[ Storage condition ]:
2~8°C

MSDS

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Hazard Codes ]:
Xi:Irritant

[ Risk Phrases ]:
R36/37/38

[ Safety Phrases ]:
S22-S26-S36/37/39

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ HS Code ]:
2924299090

Synthetic Route

Precursor & DownStream

Customs

[ HS Code ]: 2924299090

[ Summary ]:
2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

Articles

Aspartate-modified doxorubicin on its N-terminal increases drug accumulation in LAT1-overexpressing tumors.

Cancer Sci. 106 , 747-56, (2015)

L-type amino acid transporter 1 (LAT1), overexpressed on the membrane of various tumor cells, is a potential target for tumor-targeting therapy. This study aimed to develop a LAT1-mediated chemotherap...

Cell-penetrating apoptotic peptide/p53 DNA nanocomplex as adjuvant therapy for drug-resistant breast cancer.

Mol. Pharm. 11(10) , 3352-60, (2014)

Drug resistance becomes a formidable challenge against effective cancer therapy. Defective apoptosis in cancer cells is a key factor responsible for chemoresistance or radioresistance. Promoting apopt...

Design and synthesis of newN-(fluorenyl-9-methoxycarbonyl) (Fmoc)-dipeptides as anti-inflammatory agents

Eur. J. Med. Chem. 44 , 1933-40, (2009)

Twenty-four new dipeptide analogs ( 1– 24) of aurantiamide acetate were designed, synthesized, and assayed for effects on superoxide anion generation and elastase release by human neutrophils in respo...


More Articles


Related Compounds